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Eukaryotic Okazaki fragments are
initiated by an RNA/DNA primer, which is
removed before the fragments are joined.
Polymerase δ displaces the primer into a flap
for processing.  Dna2 nuclease/helicase and flap
endonuclease 1 (FEN1) are proposed to cleave
the flap.  The single-stranded DNA binding
protein, replication protein A (RPA), governs
cleavage activity.  Flap-bound RPA inhibits
FEN1.  This necessitates cleavage by Dna2,
which is stimulated by RPA.  FEN1 then cuts
the remaining RPA-free flap to create a nick
for ligation.  Cleavage by Dna2 requires that it
enter the 5'-end and track down the flap.  Since
Dna2 cleaves the RPA-bound flap, we
investigated the mechanism by which Dna2
accesses the protein-coated flap for cleavage.
Using a nuclease-defective Dna2 mutant, we
showed that just binding of Dna2 dissociates
the flap-bound RPA.  Facile dissociation is
specific to substrates with a genuine flap, and
will not occur with an RPA-coated single
strand.  We also compared the cleavage
patterns of Dna2 with and without RPA to
better define RPA stimulation of Dna2.
Stimulation derived from removal of DNA
folding in the flap.  Apparently, coordinated
with its dissociation, RPA relinquishes the flap
to Dna2 for tracking in a way that does not
allow flap structure to reform.  We also found
that RPA strand melting activity promotes
excessive flap elongation, but it is suppressed by
Dna2-promoted RPA dissociation.  Overall,
results indicate that Dna2 and RPA coordinate
their functions for efficient flap cleavage and
preparation for FEN1.
Eukaryotic DNA replication involves
synthesis of a leading strand in the direction of
parental DNA unwinding, and because of the anti-
parallel structure of DNA, a lagging strand in the
opposite direction of unwinding.  While leading
strand synthesis occurs continuously, the lagging
strand must be synthesized in a discontinuous
fashion.  Lagging strand synthesis is initiated by
the polymerase (pol) α/primase complex, which
synthesizes 8-12 nucleotides (nt) of RNA followed
by approximately 20-nt of DNA (1,2).  The pol
α/primase complex is then replaced by a complex
of the toroidal sliding clamp proliferating cell
nuclear antigen and pol δ, which is loaded onto the
DNA by the clamp loader replication factor C.
This complex synthesizes another 100-150-nt of
DNA before the primer terminus encounters the
previously synthesized downstream segment.
These segments, known as Okazaki fragments,
must then be processed to create a continuous
strand of DNA.   Since pol α does not possess
proofreading activity and synthesizes with
relatively low fidelity compared to pol δ, it is
proposed that the entire RNA/DNA primer, laid
down by pol α, is removed to maintain genome
integrity (3).  Processing of the RNA/DNA primer
is initiated when strand displacement synthesis, by
pol δ, raises the primer into a single-stranded (ss)
flap intermediate (4-6).  Removal of this flap
intermediate followed by fragment joining is
known as Okazaki fragment processing.
Several modes of Okazaki fragment
processing have been proposed to occur in
Saccharomyces cerevisiae, based on biochemical
and genetic data.  One involves complete flap
removal by flap endonuclease 1 (FEN1) (4,7).
FEN1 is a structure-specific nuclease that cleaves
at the base of 5' flap intermediates to create a nick
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(8).  In this mode, pol δ displaces the RNA/DNA
primer into short flap intermediates.  These flaps
are efficiently cleaved by FEN1.  The resultant
nicked product is then ligated by DNA ligase I.
In another proposed mode, cleavage by
the nuclease/helicase Dna2 precedes FEN1
cleavage to create a nicked product (9,10).  When
flaps reach a length of 20- to 30-nt, they are stably
bound by replication protein A (RPA) (11-13).
RPA binding prevents cleavage by FEN1, while
stimulating Dna2 cleavage, necessitating initial
flap cleavage by Dna2 (9).  Dna2, unlike FEN1,
cannot create a nick product for ligation.  Instead,
it leaves a short, approximately 5-nt flap devoid of
RPA.  FEN1 can then cleave this short flap,
creating a nick for ligation by DNA ligase I.
Recent work from our group suggests that
both pathways are employed during flap
processing (14).  By reconstructing Okazaki
fragment processing in vitro, we recently
demonstrated that pol δ displaces mostly short
flaps (<10-nt), which are readily cleaved by FEN1.
In addition to the short flaps, a minor subset of
longer flaps (10- to 30-nt) arises, which can be
bound by RPA, requiring the Dna2/FEN1
pathway.  These results suggest that the two
pathways work in parallel to resolve Okazaki
fragments during DNA replication.
S. cerevisiae Dna2 was identified during a
screen for mutants defective in DNA replication
(15,16).  It is an essential protein possessing both
ssDNA endonuclease activity and 5' to 3' ATP-
dependent helicase activity (15,17).  In addition, it
physically and genetically interacts with FEN1,
further implicating it in lagging strand replication
(18).  Recently, Dna2 was shown to possess
strand-annealing and strand exchange activities,
which may aid in the formation of a 5' flap
intermediate during flap equilibration (19).  Dna2
has subsequently been shown to interact with other
proteins involved in DNA replication, including
Pol32, RNaseH2, Sgs1, and Exo1 (20).
Furthermore, RPA was found to interact with
Dna2 to stimulate both its nuclease and helicase
activities, and the over-expression of RPA
overcame the temperature-sensitive growth of
several Dna2 mutant alleles (9,21,22).
S. cerevisiae RPA is a heterotrimeric
protein consisting of subunits Rpa1-3, each of
which is essential in yeast (23-25).  In humans,
RPA is also necessary for the reconstitution of
SV40 DNA replication (26).  Its primary role is to
stabilize ssDNA, preventing it from re-annealing
or forming secondary structure during DNA
replication, repair, and recombination (27-29).
Dna2 was shown to interact specifically with
Rpa1, the large subunit of RPA (22).  Contacts
between the two proteins were found to occur at
both the N- and C-terminal domains of both Dna2
and Rpa1.  Additionally, wild type Dna2 and RPA
were shown to form a complex on a DNA flap
substrate (9).
We previously reported that in order to
exhibit nuclease activity, Dna2 must enter the free
5'-end of a flap, and then track down the flap
toward the base for cleavage (30).  Accordingly,
the tracking requirement of Dna2 necessitates that
it encounter bound RPA molecules as it moves for
successive cleavages.  Since Dna2 is stimulated
for cleavage on flaps coated by RPA, we were
prompted to ask why the presence of RPA does
not interfere with the tracking motion of Dna2.
This question is particularly interesting since Dna2
cleavage is inhibited on flaps coated by other
ssDNA binding proteins (Escherichia coli single-
stranded binding protein and human RPA) (9,31).
In the current study, we explored the mechanism
by which Dna2 cleaves on RPA-coated flaps, and
the manner by which RPA stimulates Dna2
cleavage activity.
EXPERIMENTAL PROCEDURES
Materials—Synthetic oligonucleotides,
including the 5'-biotin and 3'-biotin conjugations,
were produced by Integrated DNA Technologies.
Radionucleotides [α-32P]dCTP and [γ-32P]ATP
were obtained from Perkin Elmer Life Sciences.
The Klenow fragment of E. coli DNA polymerase
I, polynucleotide kinase, streptavidin, and ATP
were from Roche Applied Science.  All other
reagents were the best available commercial grade.
Enzyme Expression and Purification—S.
cerevisiae Dna2 was cloned into the Sf9
baculovirus expression vector (Invitrogen).  S .
cerevisiae Dna2 E675A was created by site-
directed mutagenesis as described (32).  Both
Dna2 wild type and E675A were then expressed
and purified as described (32), except that High
Five cells were utilized.  S. cerevisiae  RPA (33)
and human RPA (13) were over-expressed and
purified as previously described.
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Oligonucleotides—Substrate primer
sequences are listed in Table 1.  Downstream
primers were labeled at either the 3'-terminus or
the 5'-terminus with [32P], as indicated in the
figures.  [α-32P]dCTP was incorporated into the 3'-
terminus by the Klenow enzyme and [γ-32P]ATP
was incorporated at the 5’-terminus using
polynucleotide kinase.  After labeling, substrates
were purified as described previously (34).  DNA
flap substrates were then annealed in 50 mM Tris-
HCl, pH 8.0, 50 mM NaCl, and 1 mM DTT and in
a 1:2:4 ratio of downstream to template to
upstream primer. The ΔG calculations for the flap
structure were done by entering the unannealed
portion of the primer sequence into mfold, for
analysis under reaction conditions (35,36).
Gel Shift Assay—The reaction volume was
20µl, which contained 5 fmol of labeled substrate
and various amounts of protein, as indicated.  The
reaction buffer consisted of 50 mM Tris-HCl, pH
8.0, 2mM DTT, 30 mM NaCl, 0.1 mg/ml bovine
serum albumin, 5% glycerol, 2 mM MgCl2, and 1
mM ATP, unless otherwise stated.  RPA was pre-
bound for 5 min at room temperature followed by
addition of Dna2 E675A for 5 min at room
temperature.  In Fig. 3 and 4, the streptavidin was
pre-incubated with the substrate for 10 min at
37°C.  For measurement of the dissociation
constants in Table 2, the substrate concentration
was lowered to 1 fmol (50 pM).  All reactions
were then loaded on pre-run 5% polyacrylamide
gels in 0.5x TBE (Invitrogen).  Gels were then
subjected to electrophoresis at 150V for 30-45
min.
Nuclease Assay—Reactions were
performed at 37°C for 10 min.  The reaction
volume was 20µ l, which contained 5 fmol of
labeled substrate and various amounts of protein,
as indicated.  The reaction buffer consisted of 50
mM Tris-HCl pH 8.0, 2mM DTT, 30 mM NaCl,
0.1mg/ml bovine serum albumin, 2 mM MgCl2,
and 1mM ATP, unless otherwise stated in figure
legends.  The reactions were stopped by addition
of 2x termination dye, consisting of 90%
formamide (v/v), 10 mM EDTA, 0.01%
bromophenol blue, and 0.01% xylene cyanol.  A
15% polyacrylamide gel, containing 7 M urea, was
then used to separate the reactions.
Strand Melting Assay—RPA strand
melting was measured using native gel
electrophoresis.  The reaction buffer consisted of
50 mM Tris-HCl, pH 8.0, 2 mM DTT, 30 mM
NaCl, 0.1 mg/ml bovine serum albumin, and 5%
glycerol with or without 1 mM ATP and 2 mM
MgCl2, as indicated in figure legends.  Substrates
(5 fmol) were incubated with various amounts of
RPA at 37°C for 15 min.  Reactions were then
stopped by addition of a 6x helicase dye,
containing 30% glycerol, 50 mM EDTA, 0.9%
SDS, 0.25% bromophenol blue, and 0.25% xylene
cyanole.   Reactions were then loaded onto 5%
polyacrylamide gels in 0.5x TBE (Invitrogen).
Gels were then subjected to electrophoresis at
150V for 30 min.
Gel Analysis—Experiments were done in
at least duplicate and representative gels are
shown.  After running conditions, gels were
transferred to filter paper (Whatmann) and dried
on a gel dryer (Bio-Rad) and vacuum (Savant).
Gels were then exposed to a phosphor screen and
analyzed by phosphor-imaging (GE Healthcare).
Analysis of the image was then performed using
ImageQuantMac, version 1.2.
C a l c u l a t i o n  o f  D i s s o c i a t i o n
Constants—After gel shift analysis, curves were fit
using nonlinear least squares regression of the
hyperbolic equation:
y = Bmax*[Protein] / (Kd+[Protein])
where y is the percent of oligonucleotide bound,
[Protein] is the concentration of protein in nM,
Bm a x  is the maximum binding, and Kd is the
equilibrium dissociation constant.
RESULTS
Dna2 Removes Flap-Bound RPA—Since
Dna2 is necessary to cleave flaps bound by RPA,
we planned to determine the mechanism by which
Dna2 gains access to the flap.  Previously, it had
been proposed that RPA dissociates as a
consequence of flap cleavage by Dna2 (9).
However, another possibility is that Dna2
dissociates RPA from the flap to gain access to
binding sites for tracking and cleavage.  To
distinguish these hypotheses, we tested the ability
of the nuclease-defective mutant Dna2 E675A to
dissociate RPA.  This mutant Dna2 would allow
us to establish whether RPA dissociation depends
on cleavage.  Reactions employed a double flap
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substrate with a 53-nt flap.  RPA was pre-bound to
the substrate prior to the addition of Dna2 E675A
(see Experimental Procedures).  Pre-binding of
RPA allowed us to observe the subsequent effects
of Dna2 addition on flap-bound RPA.  Saturating
amounts of RPA were pre-bound to the flap so that
we could assess Dna2 binding to RPA-bound
flaps, without having to simultaneously interpret
results of Dna2 binding to naked flaps.  Gel shift
analysis was then carried out to determine whether
Dna2 and/or RPA were bound to the labeled flap
substrate (Fig. 1).
We previously demonstrated that although
the Dna2 E675A mutant is devoid of nuclease
activity, it retains both substrate binding and
helicase activities (34).  These properties of the
Dna2 E675A allowed us to also assess the effects
of helicase function on Dna2 binding to the RPA-
coated substrate.  To accomplish this assessment,
binding reactions were carried out in the presence
or absence of ATP, which is required for Dna2
helicase function.
With RPA alone (Fig. 1), the major band
in lanes 2 and 9 corresponds to the binding of two
RPA molecules to the 53-nt flap, with the minor
band corresponding to one RPA molecule.  This
interpretation is consistent with the banding
pattern changes seen in an RPA concentration
titration on the same substrate, which showed
binding of one RPA and then two (data not
shown).  Dna2 was then titrated into the reaction.
As the amount of Dna2 increased, we observed a
shift from an RPA-bound band to a Dna2-bound
band (Fig. 1, lanes 3-6, 10-13).  Similar results
were observed on 37-nt and 30-nt flap substrates
(data not shown).  These results are consistent
with the idea that Dna2 removes RPA from the
flap in a cleavage independent manner, allowing
Dna2 access to the flap for cleavage.  However,
the results do not exclude the possibility that Dna2
cleavage activity aids in further destabilizing RPA
binding to the flap.
Interestingly, the addition of ATP did not
significantly alter the shift to the Dna2-bound flap
(Fig. 1, compare lanes 3-6 and 10-13).   However,
we observed a minor accumulation of a super-
shifted product, in the presence of both Dna2 and
RPA (lane 6).  This product likely represents an
intermediate in which both Dna2 and RPA are
bound to the flap substrate.  Since ATP is thought
to aid Dna2 tracking on the flap (30), the absence
of ATP might slow RPA removal because tracking
is impaired.
RPA Binds Flaps with a Higher Affinity
than that of Dna2—To assure that Dna2
replacement of RPA (Fig. 1) derived from an
active dissociation process and was not based on a
simple difference between binding affinities, we
compared the dissociation constants of RPA and
Dna2 (Table 2).  Increasing amounts of Dna2 or
RPA were bound to a fixed amount of the labeled
53-nt flap substrate.  Gel shift analysis was then
performed to assess binding.  The data were then
fit by nonlinear least squares regression to
determine relative binding affinities (Table 2).
The substrate concentration was lowered to assure
equi l ibr ium binding (see Experimental
Procedures).  The dissociation constant for RPA
binding to a 50-nt segment of ssDNA was
previously measured to be approximately 0.15 nM
(37).  Here, we measured the dissociation constant
of RPA binding to the 53-nt flap substrate to be
0.35 nM.  Both wild type Dna2 and Dna2 E675A
were tested and found to have dissociation
constants of 5.5 nM and 3.4 nM, respectively
(Table 2).  When compared with RPA binding,
Dna2 bound with an approximately 10-fold lower
relative binding affinity.  In our binding titration in
Fig. 1, the concentration of Dna2 never exceeded
5-times the concentration of RPA.  Nevertheless,
Dna2 displaced virtually all of the RPA.  These
observations suggest that, based on binding
affinities, Dna2 would not have out-competed
RPA for binding.  Instead, it must have interacted
with RPA in a specific manner to dissociate the
higher affinity RPA.
Removal  of  RPA Is  Species-
Speci f ic—Previously, Kim et. al. (9,31)
demonstrated that stimulation of Dna2 by RPA is
species-specific; for example, human RPA (hRPA)
inhibits instead of stimulates S. cerevisiae Dna2
cleavage activity.  Using the 53-nt flap, we also
saw inhibition of yeast Dna2 cleavage activity by
hRPA (Fig. 2A).  Since Dna2 dissociates RPA
(Fig. 1), we tested whether dissociation is also
species-specific (Fig. 2B).  Yeast RPA (lanes 2-4)
and hRPA (lanes 6-8) were pre-bound to the flap.
When progressively greater amounts of yeast
Dna2 were then incubated with the hRPA-bound
flaps the quantity of bound hRPA was unaltered
(lanes 6-8).  The inability of yeast Dna2 to remove
hRPA from the flap might explain why single-
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stranded binding proteins from other species
inhibit Dna2 cleavage.  If the binding proteins
block either the motion or catalytic activity of
Dna2 then cleavage would be prevented.  These
data further suggest a specific protein-protein
interaction between Dna2 and RPA, which is
required for RPA removal followed by Dna2
cleavage.
Dna2 Tracking Is Not Required for RPA
Removal—Dna2 employs a tracking mechanism to
cleave on flap substrates.  If the 5'-end of the flap
is blocked by a double-stranded region or a
streptavidin-biotin conjugate then cleavage is
inhibited (30).  Significantly, a block to tracking
inhibits cleavage by Dna2, but not Dna2 binding.
Previously, we showed that Dna2 bound a flap
substrate blocked at the 5'-end by a streptavidin-
biotin conjugate (34).  Since Dna2 can bind the
flap without tracking, we asked whether it could
still remove RPA when the 5'-end of the flap was
blocked (Fig. 3).  Streptavidin was pre-incubated
with a flap containing a biotin attached to the 5'-
end.  RPA was added into the reaction and allowed
to bind the blocked substrate.  Increasing amounts
of Dna2 were then added into the reaction.
Surprisingly, Dna2 was still able to remove the
flap-bound RPA even when tracking was blocked
(Fig. 3, lanes 4-6).  The ability of Dna2 to remove
RPA on substrates blocked at the 5'-end is an
additional confirmation that cleavage is not
required for the dissociation of RPA.
RPA/Dna2 Interaction Differs on
ssDNA—To further analyze the mechanism of
RPA removal, we evaluated the effect of Dna2 on
RPA bound to a single-stranded segment of DNA
(Fig. 4).  Use of ssDNA allowed us to determine
whether structural features of the flap are required
for RPA dissociation.  A biotin was attached to the
3'-end of the ssDNA, since blocking the end may
prevent Dna2 from tracking off the DNA.  The 50-
nt sequence used was the same sequence as the 53-
nt flap minus three nucleotides at the 5'-end.
(These nucleotides were omitted because of a
length requirement for 3'-biotin modification.)
The ssDNA was prepared with and without pre-
bound streptavidin.  RPA was then bound to the
substrate followed by the addition of Dna2 and the
products were then analyzed by gel shift (Fig. 4).
Dna2 binding to the ssDNA produced two
bands, which likely correspond to one and two
molecules of Dna2 bound to DNA (Fig. 4, lane 7).
The presence of streptavidin slowed the migration
of both bands corresponding to bound Dna2, as
anticipated (lane 14).  The shift observed when
RPA was bound to the ssDNA (compare lanes 2
and 9) was similar with and without streptavidin.
By titrating progressively more RPA with the
ssDNA, we found that the similar shift resulted
from the binding of only two RPA molecules
when streptavidin was present versus three in its
absence (data not shown).  When Dna2 was
titrated into the reaction with the bound RPA in
Fig. 4, we were surprised to find that the Dna2 did
not shift the labeled ssDNA to a position that
would indicate Dna2 displacement of the RPA
(lanes 3-6, 10-13).  Instead, the initial RPA band
was super-shifted to a higher mobility complex.
This shift likely corresponds to the binding of both
Dna2 and RPA.  The shifting pattern was not
significantly altered by the presence or absence of
streptavidin (compare lanes 1-7 and 8-14).  In
addition, the conversion from an RPA band to the
super-shifted band was incomplete at the highest
Dna2 concentration with ssDNA, whereas the
same concentration of Dna2 achieved almost
complete RPA dissociation with the flap substrate
(compare Fig. 4, lanes 6 and 13 to Fig. 1, lanes 6
and 13).  From these results it is difficult to assess
how Dna2 and RPA might interact and bind the
ssDNA.  It is readily apparent, however, that the
interactions of RPA and Dna2 on ssDNA are
different than those on a flap substrate (compare
Fig. 4 and Fig. 1).
RPA Stimulates Dna2 to Cleave More
Efficiently and Past the Flap Base—We expected
that detailed examination of the effects of RPA
interaction on the catalytic activities of Dna2
would reveal more about the movements of both
Dna2 and RPA on flaps.  Previous studies have
shown RPA stimulation of both Dna2 helicase and
cleavage activities (9,10).  To further examine the
manner in which RPA stimulates Dna2 cleavage,
we analyzed the cleavage patterns of Dna2 with
and without RPA.  Since Dna2 cleaves multiple
times on the DNA and must enter at the 5'-end for
tracking and cleavage (17,30,38), we could
visualize both the first and last cleavage sites of
Dna2 by radiolabeling the flap substrates at either
the 5'- or 3'-end of the flap-primer, respectively.
Denaturing PAGE was used to determine the
location of the first cleavage site (5' radiolabel)
and the last cleavage site (3' radiolabel) (Fig. 5).
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When comparing the cleavage patterns with and
without RPA present, we saw a shift in cleavage
with respect to both the first and last sites.  It is
interesting to note that the stimulation of Dna2
cleavage activity by RPA is lower on the 30-nt
flap substrate that we employed than has been
previously observed with other substrates
(9,10,38).  The stimulation by RPA is about two-
fold or less, a value that will be addressed later in
the results (Fig. 7).  In Fig. 5A, the first cleavages
by Dna2 were distributed along the length of the
flap.  The distribution was shifted upon the
addition of RPA (Fig. 5A, lanes 4-7), with the first
cleavages occurring closer to the 5'-end of the flap.
This result suggests that Dna2 becomes more
efficient at cleavage once it begins tracking onto
the 5'-end of the flap substrate, because the bound
RPA stimulates Dna2.  Alternatively, the Dna2
cleavage pattern could simply be shifted because
RPA binding to the flap decreases the amount of
exposed DNA accessible to Dna2 for cleavage.
Next we examined the final cleavage site
positions (Fig. 5B).  When Dna2 alone was
incubated with the flap substrate the furthest
cleavage site occurred near the base of the flap
(lane 3).  Upon addition of RPA, the cleavage
distribution was shifted further down the flap.  Not
only were the sites of cleavage shifted closer to the
base of the flap but cleavage was also increased
past the flap base into the originally annealed
portion of the primer (Fig. 5B, lanes 4-7).
Previously, Dna2 was shown to cleave
past the flap base in high ATP concentrations and
RPA had also been shown to stimulate Dna2
helicase function (10,21,32,38).  Based on these
data, we presumed that the shift further down the
flap and into the originally annealed region was
caused by RPA stimulation of Dna2 helicase
activity.  To test this expectation, Dna2 and RPA
were incubated in the absence of ATP on the 30-nt
flap substrate (data not shown).  We were
surprised to see that the cleavage patterns were the
same as those in Fig. 5B.  To assure that no
residual ATP was purified with Dna2, we
performed the same experiment with the helicase
deficient mutant Dna2 K1080E (Fig. 5C) and still
found cleavage further down the flap and into the
annealed region in the presence of RPA.  This
suggests that cleavage into the originally annealed
portion of the primer derives from a property of
RPA and not Dna2 helicase function.
 RPA Strand Melting Facilitates Dna2
Cleavage—Since RPA is known to have strand
melting activity (39), we wondered whether the
cleavage into the originally annealed region
occurred because the RPA melted the double
strands near the flap base.  To test this idea,
increasing amounts of RPA were incubated with
the 30-nt flap substrate, used in Fig. 5.  The
reaction products were then resolved by non-
denaturing PAGE (Fig. 6A).  RPA was able to
fully displace the radiolabeled flap-primer in a
protein concentration-dependent manner (Fig. 6A).
The annealed portion of this flap had a GC-content
of 52% (see Table 1).  AT-rich regions have
previously been shown to promote RPA strand
melting activity (40).  Accordingly, we tested
several other flap substrates with a >75% GC-
content in the annealed region.   These substrates
exhibited virtually no RPA-induced unwinding nor
Dna2 cleavage past the flap base in the presence of
RPA (data not shown and Fig. 7A).
RPA strand melting is suppressed by
increased magnesium concentration (41).  Since
the experiments in Fig. 6A were done in the
absence of MgCl2 and ATP, we tested whether
unwinding would still occur under more
physiological conditions (2 mM MgCl2 and 1 mM
ATP).  Consistent with previous studies, RPA
strand melting was inhibited on the 30-nt flap
substrate, used in Fig. 6A, when MgCl2 and ATP
were added to the reaction (Fig. 6B).  While RPA
strand melting was inhibited, the assay only
measured the complete removal of the primer and
so did not account for partial melting.  Partial
melting of the primer would account for Dna2
cleavage at sites past the original base of the flap
as we observed (see Fig. 5B and C), even though
the primer was not completely removed when
MgCl2 and ATP were present (Fig. 6B).
Since RPA strand melting was more active
on AT-rich regions of DNA (40), we altered the
nucleotide composition to increase the amount of
RPA strand melting with MgCl2 and ATP.   We
modified the 30-nt flap substrate, used in Fig. 6A,
to create an AT-rich region in the annealed portion
of the labeled primer (see Table 1). The GC-
content in the annealed region was lowered from
52% to 33%.  This AT-rich substrate was then
used to measure RPA strand melting in Fig. 6C
and D.  We first tested RPA strand melting
without MgCl2 and ATP present (Fig. 6C), for
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comparison with the previous flap substrate used
in Fig. 6A.  We saw a significant increase in strand
unwinding (compare Fig. 6A, and 6C).  RPA
unwinding activity was then tested in the presence
of 2 mM MgCl2 and 1 mM ATP (Fig. 6D).  While
RPA strand melting was lowered, we still saw a
significant amount of substrate melting on the AT-
rich substrate. Based on these findings, we
propose that RPA strand melting activity can
facilitate flap elongation under physiological
conditions.
RPA Removal of DNA Secondary
Structure Promotes Dna2 Cleavage —RPA strand
melting was previously shown to aid Dna2
cleavage activity (21).  In the study, a flap
substrate able to form a 10-bp duplex in the central
region of the flap was used to show that RPA
improved Dna2 cleavage past the duplex.  Since
these results were not compared to results with an
unstructured flap, we tested a 30-nt poly-dT flap
substrate to determine whether stimulation was
solely due to RPA strand melting activity.  The
unstructured flap was compared with two
structured flaps, one predicted to form a 6-bp
duplex (ΔG = -3.3) and another with a potential
18-bp duplex (ΔG = -21) (see Table 1).  These
latter substrates also contain a GC-content of
>75% in the annealed portion of the labeled flap-
primer, which inhibited strand melting of the
annealed region by RPA (data not shown).
Dna2 and increasing amounts of RPA
were incubated with the flaps and the cleavage
products were analyzed by denaturing PAGE (Fig.
7).  The addition of RPA produced little increase
in the amount of Dna2 cleavage of both the
unstructured flap and the 18-bp duplex, while the
6-bp duplex showed a significant increase in
cleavage activity (compare Fig. 7, lanes 4-7, 11-
14, and 18-21).  Consideration of the expected
melting properties of RPA provides a plausible
explanation for these results.  The unstructured
flap has no secondary structure to hinder
movement or cleavage by Dna2, and so RPA
would not stimulate Dna2.   The 18-bp duplex
structure may be too stable for RPA to fully melt,
preventing RPA from stimulating Dna2.  The 6-bp
duplex structure may be just the right stability for
RPA melting such that it promotes Dna2 cleavage
activity.
The RPA-induced shift in cleavage
pattern, apparent with the 18-bp duplex substrate,
can be explained by partial melting of the duplex
by RPA followed by Dna2 cleavage (Fig. 7, lanes
17-21).  Despite the lack of increased cleavage
product on the unstructured flap, the addition of
RPA did shift the final Dna2 cleavage site further
down the flap (Fig. 7, lanes 4-7) and decreased the
size of the first product (data not shown), similar
to the results in Fig. 5.  Based on these findings,
we can conclude that the removal of structure is a
major, but not complete determinant of RPA
effects on Dna2 cleavage activity.  This idea is
consistent with other reports of increased Dna2
cleavage activity by RPA, in which the flaps used
were predicted to contain DNA secondary
structure (9,10,42,43).  Additionally, the poor
RPA stimulation of Dna2 in Fig. 5 is likely
explained by the weak DNA secondary structure
of the 30-nt flap substrate (ΔG = -1.2).  However,
RPA stimulation of Dna2 does appear to be
limited to the strand melting capacity of RPA,
since stimulation was not observed on the more
stable 18-nt duplex (Fig.7A, lanes 17-21).
DISCUSSION
In one proposed pathway of eukaryotic
Okazaki fragment processing, the 5'-end region of
the fragment is displaced into a flap long enough
to bind RPA (9,42,43).  The RPA stimulates the
tracking and cleavage activity of the Dna2
helicase/nuclease, which cleaves the flap to a
length that does not support RPA binding,
allowing FEN1 access.  In this study, we explored
the mechanism by which Dna2 enters and cleaves
an RPA coated flap.  Using a nuclease-defective
mutant of Dna2 (E675A), we showed that Dna2
removes RPA before the flap is reduced in length.
This result is striking since RPA binds DNA with
such high affinity and, in fact, binds more tightly
than Dna2 (Table 2).  In addition, we have
examined the mechanism of RPA stimulation by
Dna2 and found that RPA strand melting activity
increases Dna2 cleavage through the removal of
DNA secondary structure.
Dna2 and RPA have been shown to
interact physically and RPA stimulates Dna2
cleavage activity (9,22).  Based on these
observations, our initial hypothesis was that Dna2
binds to flaps coated with RPA, allowing the Dna2
and RPA to bind each other.  Since Dna2 requires
tracking to cleave the flap, we envisioned that
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Dna2 would enter at the 5'-end and track down the
flap associating with successive RPA molecules.
The interactions would stimulate Dna2 to cleave
the flap, releasing a mixture of RPA-bound flap
segments, free RPA, and free DNA.  Following
cleavage by Dna2, the remaining short flap would
be free of RPA for subsequent tracking and
cleavage by FEN1.  Instead, by using the Dna2
cleavage mutant, we found that Dna2 dissociates
RPA independent of the cleavage process (Fig. 1).
We believe that this is indicative of an RPA
remodeling event caused by Dna2, which lowers
the binding affinity of RPA.  Since our reactions
were done with a nuclease-defective Dna2 mutant,
we cannot exclude the possibility that concurrent
Dna2 cleavage activity aids in further
destabilization of RPA binding.
A major function of RPA within the cell is
to coat ssDNA, reducing its melting temperature,
thus preventing the formation of secondary
structure and reannealing (23-25).  RPA must then
be removed or displaced to permit other proteins
access to the DNA.  Fanning and colleagues have
proposed that displacement occurs through
protein-protein interactions, which remodel the
conformation of RPA from an extended (high
affinity) to a more compact (low affinity) form
(27,44).  The weakly bound form of RPA is then
readily displaced by other proteins, allowing
enzyme access to the DNA.  We believe that Dna2
interacts with RPA in a similar manner to elicit its
dissociation.  Additionally, we have shown that
RPA stimulates Dna2 by the removal of DNA
secondary structure (Fig. 7).  In order for this to
occur, RPA must be displaced coordinately with
the nearby binding of Dna2.  This is the only way
that we can visualize for RPA to relinquish the
DNA to Dna2 before reformation of stable
secondary structures.
Moreover, the ability of Dna2 to
quantitatively dissociate RPA may require
polymer structure unique to a flap substrate, since
Dna2 does not remove RPA from ssDNA but
instead forms an RPA/Dna2 complex (Fig. 4).
Possibly, Dna2 must also be conformationally
altered by initial interaction with the base of the
flap, before it can accomplish efficient removal of
RPA.  Additional studies are required to elucidate
why binding and dissociation of RPA by Dna2 did
not occur on ssDNA but these results indicate the
importance of the flap structure.
Consistent with this interpretation, we
discovered that tracking of Dna2 on the flap is not
required for RPA removal (Fig. 3).  We previously
reported that Dna2 binds to a flap substrate even
when tracking is blocked by a biotin-streptavidin
at the flap 5'-end (34).  When Dna2 binds in this
non-tracking mode cleavage cannot occur but the
Dna2 can still clear the flap of RPA, thus allowing
cleavage by either another Dna2 molecule or
FEN1.  This would allow more rapid progression
toward the final product, even if Dna2 binds the
flap in the non-tracking mode.  We have also
considered that both Dna2 and RPA are proposed
to be involved in overlapping cellular pathways,
such as DNA repair, recombination, and telomere
maintenance (20,27-29,45-48). Dissociation of
RPA by Dna2 could extend to these other
pathways in which RPA removal is necessary for
further processing of the DNA.
To better understand how RPA alters the
movements and nuclease functions of Dna2 on the
flap, we conducted a detailed analysis of the Dna2
cleavage pattern in the presence of RPA.  As long
flaps arise during lagging strand replication, they
have an increasing propensity to form DNA
secondary structure.  When this structure becomes
stable enough to interfere with tracking, it can
inhibit the nuclease activity of both Dna2 and
FEN1.  Dna2 helicase activity has previously been
shown to provide little aid to tracking on
structured flap substrates.  In one study, Dna2
helicase function was shown to enhance Dna2
cleavage past a predicted 10-nt duplex in the flap
region, which blocked Dna2 cleavage (21).  While
cleavage past the duplex was increased, the
predominant products still occurred before the
duplex region.   In another study by our group,
Dna2 helicase activity provided only minor
stimulation of Dna2 cleavage past predicted
duplex regions in the flaps, as the amount of
structure increased (38).  Furthermore, we have
shown here that cleavage by Dna2 alone is
significantly reduced on a structured flap,
containing a predicted 6-nt duplex, compared to
cleavage on an unstructured flap (Fig. 7).  These
results indicate that Dna2 helicase activity alone is
not sufficient to remove stable DNA secondary
structure.
In our current work, the presence of RPA
stimulated Dna2 cleavage on the predicted 6-nt
duplex flap but not an unstructured flap (Fig. 7).
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RPA not only increased Dna2 cleavage but shifted
cleavage further down the flap past the duplex.
These results allow us to attribute Dna2
stimulation to relief of DNA secondary structure
by RPA.  Although, when a flap with a predicted
18-nt duplex was used, Dna2 cleavage was not
increased, suggesting that RPA strand melting
capacity is limited.
While RPA strand melting may not fully
unwind very stable structures, one could imagine
that in vivo RPA would hinder such stable
structures from forming.  Reconstitution studies of
Okazaki fragment processing have shown that a
small fraction of flaps formed dynamically during
lagging strand synthesis escape FEN1 cleavage
and reach a length to which RPA can bind (14).
Since RPA is an abundant protein within the
nucleus and RPA binds ssDNA very rapidly (27-
29), flaps not readily cleaved by FEN1 would be
stably bound by RPA once they reach an adequate
length.  In this sense, RPA binding prepares the
flap for Dna2 cleavage and stimulates cleavage
activity by the removal of secondary structure.
The cooperative action of RPA strand melting and
the additional helicase activity of Dna2 may also
be required if flaps have already formed stable
secondary structure prior to RPA binding.
From these findings, we have developed a
model of how RPA and Dna2 interact during
Okazaki fragment processing (Fig. 8).  When long
flaps arise, they have a greater tendency to form
DNA secondary structure.  In the absence of RPA,
Dna2 cleavage would be inhibited on these
structured flaps.  Binding by RPA would melt out
the structure in the flap.  Our current results show
that Dna2 requires a flap structure for facile
dissociation of RPA.   Based on these
observations, we propose that Dna2 recognizes the
flap and begins the tracking process.  It then
dissociates RPA, moving through the ssDNA
before the reformation of DNA secondary
structure.  During this process it cuts the flap to
successively shorter lengths.  Following cleavage
by Dna2, the remaining short flap, which RPA
cannot bind, would then be subject to cleavage by
FEN1, creating a nick for ligation.
We must also reconcile this model with
the observation that Dna2 can dissociate RPA
without tracking.  Dna2 must track to cleave, and
must acquire the unfolded DNA at the moment of
RPA dissociation.  In view of these facts, it is
reasonable to conclude that RPA dissociation is
accomplished during tracking.  Blocked tracking is
an unnatural condition during Okazaki fragment
processing.  The fact that RPA dissociation can
still be accomplished reveals a feature of the
dissociation mechanism, but may not represent the
coordinated interactions that occur when tracking
is allowed.
An additional value of the facile
dissociation of RPA by Dna2 is the likelihood that
Dna2 slows RPA-promoted flap elongation.  We
and the Seo group have proposed that the two-
nuclease pathway for flap removal has evolved to
cleave flaps that become too long for processing
by FEN1 alone (9,14).  While RPA strand melting
activity would aid Dna2 in flap cleavage, an
additional consequence of strand melting is the
potential for further flap elongation.  RPA strand
melting capacity was shown to bind to AT-rich
regions of the SV40 genome and catalyze
unwinding of the DNA (40).  Additionally, we
have demonstrated that RPA stimulates Dna2
cleavage into the annealed portion of the primer,
as a consequence of RPA strand melting activity
(Fig. 5).  RPA-promoted strand melting, as
assessed by RPA unwinding, was increased when
AT-rich downstream double stranded regions were
examined and diminished when AT-content was
minimized.  We suggest that Dna2-directed
dissociation of RPA would help to slow flap
displacement,  minimizing unnecessary
degradation of the DNA portion of Okazaki
fragments during processing.
Finally, the interaction between RPA and
Dna2 appears to be specific to proteins from the
same species.  Previous analysis of Dna2 cleavage
reactions with RPA revealed that RPA of the same
species stimulated Dna2 cleavage, but when
homologues of RPA and Dna2 from different
species were tested together Dna2 cleavage was
inhibited (31).  We were able to reproduce this
phenomenon using the 53-nt flap substrate with
hRPA and yeast Dna2 (Fig. 2A).  We extended
this analysis to show that association of bound
hRPA by yeast Dna2 is inhibited suggesting that
dissociation of the flap-bound RPA is required for
cleavage.  Even hRPA, which shares
approximately 30% identical and 45% similar
sequence homology with S. cerevisiae RPA (28),
is unable to be dissociated by Dna2 (Fig. 2B).
This contrasts with the facile dissociation of RPA
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seen when yeast RPA and Dna2 were tested (see
Fig. 1).  Importantly, this result is also further
confirmation that Dna2-promoted dissociation of
RPA is a very specific phenomenon, and not a
consequence of a simple binding competition.
Specificity is additionally supported by results
with the E. coli homolog of RPA, SSB, which was
found to inhibit yeast Dna2 cleavage (9).  Taken
together, we can conclude that Dna2 specifically
interacts with RPA to facilitate dissociation
followed by Dna2 cleavage.
In conclusion, we have more closely
defined the interactions between RPA and Dna2.
Our findings show that RPA strand melting
capacity can relieve the DNA secondary structure
in the flap to facilitate rapid and efficient tracking
and cleavage by Dna2.  Concurrently, Dna2
dissociates the flap-bound RPA to access the flap
for cleavage, leaving a short RPA-free flap.  FEN1
cleavage then creates a nicked product for
subsequent ligation and fragment joining.  In this
fashion, Dna2 and RPA have evolved to
coordinate their functions to ensure proper primer
removal during Okazaki fragment processing.
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FIGURE LEGENDS
Figure 1.  Dna2 dissociates RPA from flap substrates.  Gel shift analysis was performed with 100 fmol
of RPA, 5 fmol a 53-nt flap substrate (D1:U1:T1), and increasing amounts of Dna2 E675A (50, 100, 200,
500 fmol).  Lanes 1-7 contain no ATP and lanes 8-14 contain 1 mM ATP.  RPA was pre-bound to the
substrate as indicated in Experimental Procedures.  Dna2 was then added into the reaction (lanes 3-6 and
10-13).  Lane 1 is the substrate alone.  Lanes 2 and 9 are substrate with RPA (100 fmol) alone and lanes 7
and 14 are substrate with Dna2 (500 fmol) alone.  The substrate used is depicted above the gel and the
asterisk indicates the site of the 5' 32-P-radiolabel.
Figure 2.  Yeast Dna2 cannot dissociate human RPA.  A , Dna2 (50 fmol) cleavage activity was
measured by denaturing PAGE with increasing amounts of hRPA (10, 50, 100, 200, 500 fmol) and 5 fmol
of the 53-nt flap substrate (D1:U1:T1).  B, Gel shift analysis was performed with 100 fmol of either RPA
(lanes 2-4) or hRPA (lanes 6-8), 5 fmol the 53-nt flap substrate (D1:U1:T1), and increasing amounts of
Dna2 E675A (100, 200 fmol).  RPA was pre-bound to the substrate as indicated in Experimental
Procedures.  Dna2 was then added into the reaction (lanes 3-4 and 7-8).  Lanes 1 and 5 are the substrate
alone and substrate with Dna2 E675A (500 fmol) alone, respectively.  The substrate, used is both A and B,
is depicted above the gel in A, and the asterisk indicates the site of the 5' 32-P-radiolabel.
Figure 3.  Dna2 tracking mechanism is not required for RPA dissociation.  Gel shift analysis was
performed with 100 fmol of RPA, 5 fmol of the 53-nt flap substrate (D2:U1:T1), and increasing amounts
of Dna2 E675A (100, 200, 500 fmol).  The substrate was incubated with streptavidin (250 fmol) prior to
pre-binding with RPA as indicated in Experimental Procedures.  Dna2 was then added into the reaction
(lanes 4-6).  Lanes 1, 2, and 3 are the substrate alone, substrate with Dna2 E675A (500 fmol) alone, and
substrate with RPA (100 fmol) alone, respectively.  The substrate is depicted above the gel.  The asterisk
indicates the site of the 3' 32-P-radiolabel, and B indicates the 5' biotin.
Figure 4.  ssDNA alters Dna2 dissociation of RPA.  Gel shift analysis was performed with 100 fmol of
RPA, 5 fmol of the 50-nt ssDNA substrate (D3), and increasing amounts of Dna2 E675A (50, 100, 200,
500 fmol).  In lanes 8-14, the substrate was incubated with streptavidin (250 fmol) prior to pre-binding
with RPA as indicated in Experimental Procedures.  Dna2 was then added into the reaction (lanes 3-6 and
10-13).  Lanes 1, 2, and 7 are the substrate control alone, substrate with Dna2 E675A (500 fmol) alone,
and substrate with RPA (100 fmol) alone, respectively, without streptavidin.  Lanes 8, 9, and 14 are the
substrate alone, substrate with Dna2 E675A (500 fmol) alone, and substrate with RPA (100 fmol) alone,
respectively, with streptavidin.  The substrate is depicted above the gel.  The asterisk indicates the site of
the 5’ 32-P-radiolabel, and B indicates the 3’ biotin.
Figure 5.  Dna2 cleavage patterns in the presence of RPA.  Reactions were performed with 5 fmol of
the 30-nt flap substrate (D4:U1:T1).  A, Cleavage by wild type Dna2 (10 fmol) was measured on a 5'-
radiolabeled flap substrate with increasing amounts of RPA (10, 50, 100, 500 fmol).  B, Cleavage
reactions were performed as in A, except a 3'-radiolabeled flap substrate was used.  C, Dna2 K1080E (5
fmol), helicase deficient mutant, was used to measure cleavage activity with increasing amounts of RPA
(10, 50, 100, 200 fmol), in the absence of ATP, using the 3'-radiolabeled flap substrate.  In all gels, lanes
1, 2, and 3 are the substrate alone, substrate with RPA (500 fmol) alone, and substrate with Dna2 alone,
respectively.  The substrates used are depicted above the gel with the asterisk indicating the site of the 32-
P-radiolabel.
Figure 6.  RPA strand melting activity allows Dna2 cleavage past the base of the flap.  Non-
denaturing PAGE was performed to measure the strand melting activity of RPA.  A, Increasing amounts
of RPA (50, 100, 200, 500 fmol) and 5 fmol of flap substrate were incubated in the absence of MgCl2 and
ATP (lanes 2-5).  The 30-nt substrate (D4:U1:T1) used was the same as in Fig. 5B .  B, An unwinding
12
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on Septem
ber 19, 2008 
w
w
w
.jbc.org
D
ow
nloaded from
 
assay was performed as in A, except 2mM MgCl2 and 1mM ATP were included in the reaction buffer.  C,
An unwinding assay was performed as in A, except the GC-content of the 30-nt substrate was lowered
from 52% to 33% (D5:U1:T2) in the annealed region of the primer (see Table 1).  D, An unwinding assay
was performed as in C, except 2mM MgCl2 and 1mM ATP were included in the reaction buffer.  In all
cases, lane 1 represents the substrate alone.  Percent unwound is defined as
(unwound/(unwound+annealed)) x 100.  Substrate and product bands are identified.  The substrate is
depicted above the gel in A with the asterisk indicating the site of the 3' 32-P-radiolabel.
Figure 7.  Dna2 cleavage activity in the presence of RPA on unstructured and structured flap
substrates.  Dna2 (10 fmol) cleavage activity was measured by denaturing PAGE with increasing
amounts of RPA (10, 50, 100, 200 fmol) and 5 fmol of substrate.  Lanes 1, 8, and 15 are substrate alone.
Lanes 2, 9, and 16 are substrate with RPA (200 fmol) alone and lanes 3, 10, and 17 are substrate with
Dna2 (10 fmol) alone.  Lanes 1-7 contains a poly dT sequence in the flap region of the substrate
(D6:U2:T3).  Lanes 8-14 contain a 6-nt duplex in the flap region (D7:U2:T3) with lengths a=6-nts, b=6-
nts, c=4-nts, and d=10-nts.  Lanes 15-21 contain an 18-nt duplex in the flap region of the substrate
(D8:U2:T3) with lengths a=12-nts, b=18-nts, c=6-nts, and d=33-nts.  Percent cleavage is defined as
(cleavaed/(cleaved+uncleaved)) x 100.  The substrates are depicted above the gel with the asterisk
indicating the site of the 3' 32-P-radiolabel.
Figure 8.  A model of the proposed RPA/Dna2 interaction during Okazaki fragment processing.
Strand displacement synthesis by pol δ creates flap intermediates that can become long and form DNA
secondary structure.  This structure inhibits cleavage activity by Dna2 or FEN1.  RPA then uses its strand
melting capacity to remove the structure and bind the flap.  Dna2 tracking is then employed to remove
RPA from the flap and cleave.  Finally, the remaining RPA-free flap is cleaved by FEN1 to create a nick
for ligation by DNA Ligase I.
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(5' - 3')
Primer Length (nt)                                                           Sequence
Downstream*^
D1 76 GTA CCG AGC TCG AAT TCG CCC GTT TCA CGC CTG TTA GTT AAT TCA CTG GCC GTC 
 GTT TTA CAA CGA CGT GAC TGG G
D2 76 GTA CCG AGC TCG AAT TCG CCC GTT TCA CGC CTG TTA GTT AAT TCA CTG GCC GTC 
 GTT TTA CAA CGA CGT GAC TGG G
D3 50 GTA CCG AGC TCG AAT TCG CCC GTT TCA CGC CTG TTA GTT AAT TCA CTG GC
D4 53 TTC ACG CCT GTT AGT TAA TTC ACT GGC CGT CGT TTT ACA ACG ACG TGA CTG GG
D5 53 TTC ACG CCT GTT AGT TAA TTC ACT GGC CGT AGT TTT ACA ACG ATG TGA CTA AA
D6 53 TTT TTT TTT TTT TTT TTT TTT TTT TCC ACC CGT CCA CCC GAC GCC ACC TCC TG
D7 55 AGG TCT CGA CTA ACT CTA GTC GTT GTT CCA CCC GTC CAC CCG ACG CCA CCT CCT G
D8 97 TTT TTT TTT TTT AGG TCT CGA GGC CTG CTC TAT TAT GAG CAG GCC TCG AGA CCT
  ACG TAG AGC TGT TTC CCA CCC GTC CAC CCG ACG CCA CCT CCT G
Upstream
U1 28 CGC CCA GGG TTT TCC CAG GTC ACG GAC A
U2 26 CGA CCG TGC CAG CCT AAA TTT CAA TA
Template
T1 49 GCC CAG TCA CGT CGT TGT AAA ACG GGT CGT GAC TGG GAA AAC CCT GGC G
T2 49 GTT TAG TCA CAT CGT TGT AAA ACT GGT CGT GAC TGG GAA AAC CCT GGC G
T3 54 GCA GGA GGT GGC GTC GGG TGG ACG GGT GGA TTG AAA TTT AGG CTG GCA CGG TCG
*Bolded nucleotides are biotinylated
^Underline indicates foldback region
Table 1:  Oligonucleotides 
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Table 2:  Relative Binding Constants
Protein Kd (nM)*
RPA     0.35  ± 0.10
Dna2 WT     5.5    ± 0.77
Dna2 E675A     3.4    ± 0.50
*Apparent dissociation constants measured by gel
shift anlaysis.  Results are an average of two
independent experiments.
15
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on Septem
ber 19, 2008 
w
w
w
.jbc.org
D
ow
nloaded from
 
16
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on Septem
ber 19, 2008 
w
w
w
.jbc.org
D
ow
nloaded from
 
17
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on Septem
ber 19, 2008 
w
w
w
.jbc.org
D
ow
nloaded from
 
18
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on Septem
ber 19, 2008 
w
w
w
.jbc.org
D
ow
nloaded from
 
19
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on Septem
ber 19, 2008 
w
w
w
.jbc.org
D
ow
nloaded from
 
20
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on Septem
ber 19, 2008 
w
w
w
.jbc.org
D
ow
nloaded from
 
21
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on Septem
ber 19, 2008 
w
w
w
.jbc.org
D
ow
nloaded from
 
22
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on Septem
ber 19, 2008 
w
w
w
.jbc.org
D
ow
nloaded from
 
23
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on Septem
ber 19, 2008 
w
w
w
.jbc.org
D
ow
nloaded from
 
